Financial Data and Key Metrics Changes - The Q3 results were disappointing, with the outlook for Q4 and into 2025 below expectations and goals [4][5] - The company plans to temporarily reduce its quarterly dividend starting in Q1 2025 to support deleveraging efforts [4][5] - The expected cash flow for the year is projected to be around $800 million to $900 million, with additional cash flow anticipated from cost reduction initiatives [8][9] Business Line Data and Key Metrics Changes - The Engineered Materials (EM) business showed year-on-year EBIT growth, but challenges remain in pricing and volume, particularly in the nylon segment [31][47] - The Acetyl Chain segment has maintained strong margins despite macroeconomic headwinds, supported by a favorable cost structure and technology advantages [63][64] Market Data and Key Metrics Changes - The automotive sector has faced significant demand challenges, with European auto builds down 14% from Q2 to Q3 [13] - The company has observed a decline in demand in China, particularly in construction and coatings markets, impacting overall performance [39] Company Strategy and Development Direction - The company is focused on four priorities: reducing costs, delivering synergies, enhancing the project pipeline, and leveraging the integrated model of the Acetyl Chain [19] - There is a strong emphasis on opportunistic divestitures and optimizing the asset footprint to align with current market conditions [66] Management's Comments on Operating Environment and Future Outlook - Management acknowledged persistent macroeconomic headwinds affecting demand and cash flow, leading to the decision to cut the dividend [20][26] - There is uncertainty regarding the operating environment in 2025, with management focusing on controlling internal factors to drive performance [18][26] Other Important Information - The company recorded a $34 million impairment on trade names, primarily related to Zytel, during the third quarter [17] - Management is committed to deleveraging the balance sheet to a target of 3 times net debt to EBITDA as quickly as possible [9][51] Q&A Session Summary Question: Cash flow divestitures and deleveraging expectations - Management emphasized focusing on EBIT and cost reduction initiatives, with a typical cash flow level expected to be $800 million to $900 million [8] Question: Decline in the second half of the year - Management noted that expectations were initially stronger, but demand pressures in the automotive and industrial sectors became apparent in August [13] Question: Dividend cut rationale - The dividend cut was deemed necessary to support deleveraging efforts amid lower-than-expected cash flow [20][26] Question: Fourth quarter EBITDA outlook for EM - Management indicated that there are one-offs affecting the fourth quarter, but expects most of these to recover in Q1 2025 [16] Question: Auto market expectations - Management acknowledged that while there was an expectation of a slight uptick in auto production, demand deteriorated significantly in August [22] Question: Sustainability of acetyl chain margins - Management expressed confidence in the sustainability of margins due to global trade flows and enhanced flexibility in operations [63][64] Question: Project pipeline and market traction - Management highlighted ongoing efforts to enhance the project pipeline and focus on non-automotive applications to drive growth [49]

Earnings and Revenue - Celanese Corporation reported Q3 2024 earnings from continuing operations of $1 08 per share, down from $8 70 in the prior-year quarter [1] - Adjusted earnings were $2 44 per share, down 2 4% from $2 50 a year ago, missing the Zacks Consensus Estimate of $2 84 [1] - Revenues of $2,648 million decreased 2 7% year over year, missing the Zacks Consensus Estimate of $2,685 million [1] Segment Performance - Engineered Materials unit net sales were $1,481 million, down 3% year over year, missing the estimate of $1,609 5 million [3] - The segment reported an operating profit of $102 million and an adjusted EBIT of $237 million [3] - Acetyl Chain segment net sales were $1,190 million, down 12 7% year over year, beating the estimate of $1,162 1 million [4] - The segment generated an operating profit of $239 million and an adjusted EBIT of $276 million [4] Financial Position - Celanese ended the quarter with cash and cash equivalents of $813 million, down 31 4% sequentially [5] - Long-term debt increased 2 4% sequentially to $11,324 million [5] - Cash provided by operating activities was $79 million, and free cash flow was a negative $16 million [5] - Capital expenditures were $131 million in the quarter [5] Market and Demand - Celanese experienced sustained demand weakness in major end-markets such as paints, coatings, and construction [2] - Downturns were observed in the Western Hemisphere automobile and industrial sectors [2] - The company anticipates a deterioration in demand in Q4 due to higher-than-normal seasonal destocking in automotive and industrial markets [6] - Celanese plans to reduce output and generate cash through inventory drawdowns, expecting the destocking to last only for the quarter [6] Outlook and Strategy - Celanese expects adjusted earnings per share of around $1 25 in Q4 [7] - The company aims to create long-term shareholder value by improving earnings, reducing costs, expanding free cash flow, and deleveraging [7] Stock Performance - Celanese's shares gained 2 9% in the past year, compared to a 2 9% decline in the industry [8]

For the quarter ended September 2024, Celanese (CE) reported revenue of $2.65 billion, down 2.8% over the same period last year. EPS came in at $2.44, compared to $2.50 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $2.68 billion, representing a surprise of -1.38%. The company delivered an EPS surprise of -14.08%, with the consensus EPS estimate being $2.84.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street e ...

Celanese (CE) came out with quarterly earnings of $2.44 per share, missing the Zacks Consensus Estimate of $2.84 per share. This compares to earnings of $2.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -14.08%. A quarter ago, it was expected that this chemical company would post earnings of $2.80 per share when it actually produced earnings of $2.38, delivering a surprise of -15%.Over the last four quarters, the company h ...

Exhibit 99.2 Non-US GAAP Financial Measures and Supplemental Information November 4, 2024 In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis. Purpose The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarte ...

Celanese Corporation (CE) is scheduled to release third-quarter 2024 results after the closing bell on Nov. 4. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The company surpassed Zacks Consensus Estimate for earnings in two of the last four quarters and missed twice. CE delivered a trailing four-quarter earnings surprise of around 1.3% on average. Celanese's investment in high-return organic projects, cost-cutting initiatives and acquisition synergies are likely to have contribut ...

Wall Street analysts forecast that Celanese (CE) will report quarterly earnings of $2.84 per share in its upcoming release, pointing to a year-over-year increase of 13.6%. It is anticipated that revenues will amount to $2.68 billion, exhibiting a decline of 1.4% compared to the year-ago quarter. The current level reflects a downward revision of 3.9% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their i ...

Analyst's Disclosure: I/we have a beneficial long position in the shares of CE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give financial advice. ...

Celanese (CE) is a Zacks Rank #5 (Strong Sell) after the company missed the Zacks Consensus Estimate when the last reported on August 1 of this year. Celanese Corporation is a global hybrid chemical company. The company produces chemical substances and materials. This article will look at why this stock is a Zacks Rank #5 (Strong Sell) as it is the Bear of the Day. Description Celanese Corp. engages in the provision of technology and specialty materials businesses. It operates through the following segments ...

- 博彩 0 I 0 I on pate for 1 II 1 T kim willems Introduction Celanese (NYSE:CE) reported its second quarter for 2024 on August 1, and results came in worse than expected, with a miss on both revenues and EPS. After a major acquisition a few years ago, the company has been trying to navigate a more challenged balance sheet, a more difficult operating environment, and has been actively trying to generate synergies from its previous deal. With Q2'24 now behind the company, in this article, I'll provide my key ta ...